Member access

4-Traders Homepage  >  Shares  >  Euronext Amsterdam  >  ESPERITE    ESP   NL0009272137


News SummaryMost relevantAll newsSector news 

CRYO SAVE GROUP : -Save Group N.V.: Purchase Shares Chairman

11/03/2011 | 01:05am US/Eastern

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 16,700 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price of ?4.14 on 1 November 2011.

Following this purchase, Mr Johan Goossens is beneficially interested in 1,316,703 ordinary shares, representing approximately 14.1% of the Group's issued share capital.


Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens

Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Sean Lunn
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield

Free footage is available on

About Cryo-Save (

Cryo-Save, the leading international family stem cell bank, already stores more than 194,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).

Click here for PDF press release:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE

React to this article
Latest news on ESPERITE
03/24 ESPERITE : financial results for 2014 published, metamorphosis completed, first ..
03/19 ESPERITE : (ESP) acquires InKaryo, US start-up specialised in Bioinformatics for..
03/17 CRYO SAVE : ESPERITE (ESP) financial results for 2014 published, metamorphosis c..
03/16 UPDATE : Premaitha Inks Deal For IONA Test, Illumina Files Patent Case
03/16 Premaitha Health Inks Deal With Esperite For IONA Test
03/16 CRYO SAVE : Esperite (ESP) and Premaitha Health sign a collaboration agreement f..
02/23 CRYO SAVE : ESPERITE 2,154,000 shares exchanged today. Thank you for your intere..
02/23 CRYO SAVE : ESPERITE (Euronext ESP) pioneers first treatment worldwide of Cerebr..
02/05 CRYO SAVE : ESPERITE tackles Autism with revolutionary Genetic test
01/29 CRYO SAVE : Esperite (ESP) invests in multimillion largest clinical Genetic cent..
Duration : Period :
ESPERITE Technical Analysis Chart | ESP | NL0009272137 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes